ניירות עמדה וסקירות בינ"ל - החברה הישראלית לחקר הכבד

חדש AASLD/IDSA Hepatitis C Virus Practice Recommendations: An Online Resource

Easel Recommendations on Treatment of Hepatitis C, 2014 - Short Version


 Easel Recommendations on Treatment of Hepatitis C, 2014 - Long Version


Management of chronic hepatitis B in childhood: ESPGHAN
clinical practice guidelines Consensus of an expert panel on behalf of the European Society of Pediatric Gastroenterology, Hepatology and Nutrition: Etienne M. Sokal1, Massimiliano Paganelli,, Stefan Wirth, Piotr Socha, Pietro Vajro, Florence Lacaille, Deirdre Kelly, Giorgina Mieli-Vergani, Journal of Hepatology 2013 vol. 59 j 814–829


TIPS: 25 years later: Martin Rössle, Journal of Hepatology 2013 vol. 59 j 1081–1093


Update on primary sclerosing cholangitis: Tom H. Karlsen1,2, Kirsten Muri Boberg Journal of Hepatology 2013 vol. 59 j 571–582


Management of anemia induced by triple therapy in patients
with chronic hepatitis C: Challenges, opportunities
and recommendations: Manuel Romero-Gómez1, Marina Berenguer, Esther Molina, José Luis Cal, Journal of Hepatology 2013 vol. 59 j 1323–1330


Acute kidney injury (AKI) in cirrhosis: Should we changecurrent definition and diagnostic criteria of renal failure in cirrhosis? Vicente Arroyo, Journal of Hepatology 2013 vol. 59 j 415–417


D-livering the message: The importance of vitamin D status in chronic liver disease: Matthew T. Kitson et al.,Journal of Hepatology 2012 vol. 57 j 897–909


S-adenosylmethionine (SAMe) therapy in liver disease: A review of current evidence and clinical utility: Quentin M. Anstee et al.,Journal of Hepatology 2012 vol. 57 j 1097–1109


Hepatorenal syndrome, MELD score and liver transplantation - An evolving issue with relevant implications for clinical practice: Paolo Angeli et al., Journal of Hepatology 2012 vol. 57 j 1135–1140


Assessment of risk for non-hepatic surgery in cirrhotic patients: Prashant Bhangui et al., Journal of Hepatology 2012 vol. 57 j 874–884


The option of HBIG-free prophylaxis against recurrent HBV: Alyson N. Fox et al., Journal of Hepatology 2012 vol. 56 j 1189–1197


EASL Clinical Practice Guidelines: Management of chronic hepatitis B virus infection: European Association for the Study of the Liver, Journal of Hepatology 2012 vol. 57 j 167–185


Review and Management of Drug Interactions With Boceprevir and Telaprevir: Jennifer J. Kiser et al.,HEPATOLOGY, Vol. 55, No. 5, 2012


The Diagnosis and Management of Non-Alcoholic Fatty Liver Disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association: Naga Chalasani et al., HEPATOLOGY, Vol. 55, No. 6, 2012


Follow-up and indications for liver biopsy in HBeAg-negative chronic hepatitis B virus infection with persistently normal ALT: A systematic review: George V. Papatheodoridis et al., Journal of Hepatology 2012 vol. 57 j 196–202


Adrenocortical Dysfunction in Liver Disease: A Systematic Review: Giuseppe Fede et al., HEPATOLOGY, Vol. 55, No. 4, 2012


EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma: Josep M. Llovet (EASL); Michel Ducreux (EORTC) et al., Journal of Hepatology 2012 vol. 56 j 908–943


Mechanisms of Disease, IgG4-Related Disease, Review article: John H. Stone et al., The new England journal of medicine; 366:539-661 February 2012


Lifestyle interventions for the treatment of non-alcoholic fatty liver disease in adults: A systematic review: Christian Thoma et al., Journal of Hepatology 2012 vol. 56 j 255–266


Boceprevir: Haripriya Maddur et al., Hepatology Volume 54, Issue 6, pages 2254–2258, December 2011


Hepatitis E: Rakesh Aggarwal et al., Hepatology Volume 54, Issue 6, pages 2218–2226, December 2011


Intensive care of the patient with cirrhosis: Jody C. Olson et al., Hepatology Volume 54, Issue 5, pages 1864–1872, November 2011


Drug therapy: Telaprevir: Michael D. Leise et al., Hepatology Volume 54, Issue 4, pages 1463–1469, October 2011


An Update on Treatment of Genotype 1 Chronic Hepatitis C Virus Infection: 2011 Practice Guideline by the American Association for the Study of Liver Diseases:
Ghany et al., Hepatology, October 2011


Hepatitis B surface antigen quantification: Why and how to use it in 2011 – A core group report


Patients with liver cirrhosis suffer from primary haemostatic defects? Fact or fiction?


Hepatocellular Carcinoma


The Coagulopathy of Chronic Liver Disea


Idiopathic noncirrhotic portal hypertension


Terlipressin: an asset for hepatologists!


A diagnostic approach to hyperferritinemia with a non-elevated transferrin saturation


EASL Clinical Practice Guidelines: Management of hepatitis C virus infection


Autoimmune hepatitis


Diagnosis and management of hemochromatosis: 2011 Practice Guideline by the American Association for the Study of Liver Diseases.


revised classification renal dysf in cirrhosis


Risk of chronic kidney disease in patients with non-alcoholic


Management of hepatitis C virus genotype 4


טריגליצרידים ומחלות קרדיווסקולאריות נייר עמדה של ארגון הלב האמריקאי


נייר עמדה בנושא סרטן הכבד של החברה האמריקאית לחקר הכבד

Hepatology Volume 53, 2011


Management of Hepatocellular Carcinoma: An Update

Jordi Bruix,1 and Morris Sherman2
Hepatology Volume 53, Issue 3, pages 1020–1022, March 2011


Vitamin D Insufficiency

Clifford J. Rosen, M.D.
N Engl J Med 2011; 364:248-254 January 20, 2011


Noninvasive assessment of liver fibrosis

Stella M. Martínez, Gonzalo Crespo, Miquel Navasa, Xavier Forns
Hepatology Volume 53, Issue 1, pages 325–335, January 2011


Positron emission tomography scan for a hepatic mass

Boris Blechacz, Gregory J. Gores
Hepatology Volume 52, Issue 6, pages 2186–2191, December 2010


Hepatitis C pharmacogenetics: State of the art in 2010

Nezam H. Afdhal et al; Hepatology Volume 53, Issue 1, pages 336–345, January 2011


Overlap syndromes: The International Autoimmune Hepatitis

Group (IAIHG) position statement on a controversial issue Kirsten Muri Boberg, Roger W. Chapman, Gideon M. Hirschfield, Ansgar W. Lohse, Michael P. Manns, Erik Schrumpf, on behalf of the International Autoimmune Hepatitis Group, Journal of Hepatology 2011 vol. 54 j 374–385


Drug therapy: Rifaximin

Jasmohan S. Bajaj, Oliviero Riggio, Hepatology Volume 52, Issue 4, pages 1484–1488, October 2010


Hepcidin in human iron disorders: Therapeutic implications

Antonello Pietrangelo, Journal of Hepatology 2011 vol. 54 j 173–181


Renal and circulatory dysfunction in cirrhosis: Current management and future perspectives

Elsa Solà, Pere Ginès, Journal of Hepatology December 2010 (Vol. 53, Issue 6, Pages 1135-1145)


Revising consensus in portal hypertension: Report of the Baveno V

consensus workshop on methodology of diagnosis and therapy,  in portal hypertension Roberto de Franchis, On behalf of the Baveno V Faculty, Journal of Hepatology 2010 vol. 53 j 762–768


position statement on NAFLD/NASH based on the EASL 2009 special conference

Vlad Ratziua et al., Journal of Hepatology 2010 vol. 53 j 372–384


Medical and surgical treatment options for polycystic liver disease

Joost P.H. Drenth et al., Hepatology Volume 52, Issue 6, pages 2223–2230, December 2010


Loco-regional treatment of hepatocellular carcinoma

Riccardo Lencioni, Hepatology Volume 52, Issue 2, pages 762–773, August 2010


Hemostasis and thrombosis in patients with liver disease: The ups and downs

Ton Lisman et al., Journal of Hepatology 2010 vol. 53 j 362–371 (August 2010)


Treatment options for autoimmune hepatitis: A systematic review of randomized controlled trials

Mieke M.H. Lamers, Martijn G.H. van Oijen, Martine Pronk, Joost P.H. Drenth , Journal of Hepatology July 2010 (Vol. 53, Issue 1, Pages 191-198)


Cirrhotic cardiomyopathy

Søren Møller, Jens H. Henriksen, Journal of Hepatology July 2010 (Vol. 53, Issue 1, Pages 179-190)


EASL clinical practice guidelines for HFE hemochromatosis

European Association for the Study of the Liver, Journal of Hepatology 2010 vol. 53 j 3–22


Management of Hepatocellular Carcinoma: An Update

Jordi Bruix and Morris Sherman; HEPATOLOGY, July 2010


Fitness Versus Fatness: Moving Beyond Weight Loss in Nonalcoholic Fatty Liver Disease

Nathan A. Johnson and Jacob George, Hepatology Volume 52, Issue 1, pages 370–380, July 2010


Diagnosis and management of autoimmune hepatitis

Manns et al., Hepatology Volume 51, Issue 6, pages 2193–2213, June 2010


Peginterferon alpha-2a Is Associated with Higher Sustained Virological Response than Peginterferon alfa-2b in Chronic Hepatitis C: Systematic Review of Randomized Trials

HEPATOLOGY, Vol. 51, No. 3, 2010


Primary biliary cirrhosis: A 2010 update

Raoul Poupon, Volume 52, Issue 5, Pages 745-758 (May 2010)


Hepatobiliary Complications of Hematopoietic Cell Transplantation,

40 Years On, George B. McDonald M.D, Hepatology Volume 51, Issue 4, pages 1450–1460, April 2010


Now there are many (stages) where before there was one: In search of a pathophysiological classification of cirrhosis

Guadalupe Garcia-Tsao et al., Hepatology Volume 51, Issue 4, pages 1445–1449, April 2010


Diagnosis and Management of Primary Sclerosing Cholangitis

Chapman et al.; Hepatology Volume 51, Issue 2, pages 660–678, February 2010


The Role of Transjugular Intrahepatic Portosystemic Shunt (TIPS) in the Management of Portal Hypertension: Update 2009

Thomas D. Boyer and Ziv J. Haskal, HEPATOLOGY, January 2010


Alcoholic Liver Disease

Robert S. O’Shea, Srinivasan Dasarathy, Arthur J. McCullough; HEPATOLOGY, January 2010


Randomized Study of Peginterferon-α2a Plus Ribavirin vs Peginterferon-α2b Plus Ribavirin in Chronic Hepatitis C

GASTROENTEROLOGY 2010;138:108–115


Peginterferon Alfa-2a Plus Ribavirin Is More Effective Than Peginterferon

Alfa-2b Plus Ribavirin for Treating Chronic Hepatitis C Virus Infection GASTROENTEROLOGY 2010;138:116–122


Re-treating Patients With Chronic Hepatitis C Who Have Not Responded to Peginterferon-α2b

Ann Intern Med. 2009;150:528-540


Severe sepsis in cirrhosis

Thierry Gustot, Hepatology Volume 50, Issue 6, pages 2022–2033, December 2009


EASL Clinical Practice Guidelines: Management of cholestatic liver diseases

European Association for the Study of the Liver, Journal of Hepatology 51 (2009) 237–267


Chronic Hepatitis B: Update 2009

LOK AND MCMAHON, HEPATOLOGY, September 2009


Primary Biliary Cirrhosis

Keith D. Lindor et al, HEPATOLOGY, July 2009


Diagnosis, Management, and Treatment of Hepatitis C: An Update

Ghany et al., HEPATOLOGY, April 2009


AASLD POSITION PAPER | Liver Biopsy

Don C. et al., HEPATOLOGY, March 2009


Diagnosis and Treatment of Wilson Disease: An Update

Eve A. Roberts and Michael L. Schilsky, HEPATOLOGY, June 2008